108937 ⎘
Enzymes; Proenzymes; Compositions thereof ; Processes for preparing, activating, inhibiting, separating or purifying enzymes; Hydrolases (3) acting on ester bonds (3.1) Ribonucleases RNAses, DNAses
RNA targeting methods and compositions
#3902METHODS FOR ASSEMBLING DNA MOLECULES
#3903Method for Determining Long Non-Coding Ribonucleic Acid Interaction Proteins
#3904Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3905COMPOSITIONS AND METHODS FOR GENETIC MANIPULATION OF METHANOTROPHS
#3906TARGETED GENOME MODIFICATION USING CIRCULAR SINGLE-STRANDED DNA
#3907REGULATED GENE EDITING SYSTEM
#3908Compositions and methods for differential Cas9 gene labeling and/or editing
#3909DONOR T-CELLS WITH KILL SWITCH
#3910ENGINEERED LONG INTERSPERSED ELEMENT (LINE) TRANSPOSONS AND METHODS OF USE
#3911METHOD FOR PRODUCING GENOME-MODIFIED PLANTS FROM PLANT PROTOPLASTS AT HIGH EFFICIENCY
#3912Thermostable Cas9 nucleases
#3913Compositions and Methods for Inhibiting Intermediate Filament Tetramerization
#3914Compositions and Methods for Immunotherapy
#3915Method for modifying target nucleic acid in genome of cell
#3916Engineered enzyme
#3917Polypeptides Having DNase Activity
#3918Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas9 Fusion Protein
#3919COMPOSITIONS AND METHODS FOR MODIFYING REGULATORY T CELLS
#3920Modulators of CAS9 polypeptides and methods of use thereof
#3921DIRECTED PSEUDOURIDYLATION OF RNA
#3922Transgenic animals and transgenic embryos producing an engineered nuclease
#3923ENGINEERED CRISPR-CAS SYSTEMS AND METHODS FOR SENSITIVE AND SPECIFIC DIAGNOSTICS
#3924Methods, procedures and kits for providing maximum depth enrichment sequencing for identification for enrichment of rare genomic variants
#3925Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3926Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3927Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells using microcarriers
#3928COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS
#3929NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES AND USES THEREOF
#3930Argonaute protein mutant and use thereof
#3931Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells via viral delivery
#3932DIRECTED MODIFICATION OF RNA
#3933Nuclease domain and use thereof
#3934FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS
#3935Adeno-Associated-Virus Rep Sequences, Vectors and Viruses
#3936NOVEL TRANSCRIPTION ACTIVATOR
#3937Methods of treating non-syndromic sensorineural hearing loss
#3938Effective disinfectant system for elimination of RNA viruses
#3939Single-molecule electronic sequence detector and methods of use
#3940METHOD FOR PRODUCING GENOME-EDITED CELL
#3941COMPOSITIONS AND METHODS FOR SEQUESTERING VIRUSES
#3942Methods and compositions for nucleic acid and protein payload delivery
#3943METHODS FOR IMPROVING PRODUCTION OF BIOLOGICAL PRODUCTS BY REDUCING THE LEVEL OF ENDOGENOUS PROTEIN
#3944Chimeric DNA:RNA Guide for High Accuracy Cas9 Genome Editing
#3945THERAPEUTIC GENOME EDITING IN X-LINKED HYPER IGM SYNDROME
#3946CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#3947DEGRADATION DOMAIN MODIFICATIONS FOR SPATIO-TEMPORAL CONTROL OF RNA-GUIDED NUCLEASES
#3948CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#3949Mad nucleases
#3950GENOMIC ENGINEERING OF PLURIPOTENT CELLS
#3951DNA-BINDING PROTEIN USING PPR MOTIF, AND USE THEREOF
#3952Sequence specific antimicrobials
#3953NANOCAPSULES FOR THE DELIVERY OF CELL MODULATING AGENTS
#3954REPORTER NUCLEIC ACIDS FOR TYPE V CRISPR-MEDIATED DETECTION
#3955NUCLEIC ACID ASSEMBLIES FOR USE IN TARGETED DELIVERY
#3956GENE EDITING OF ANTICOAGULANTS
#3957CRISPR-Cas effector polypeptides and methods of use thereof
#3958Advanced genome editing
#3959Methods for screening for cancer targets
#3960Adenosine nucleobase editors and uses thereof
#3961METHODS AND COMPOSITIONS FOR MODIFYING THE VON WILLEBRAND FACTOR GENE
#3962DOUBLE KNOCK-OUT CHO CELL LINE METHOD OF ITS GENERATION AND PRODUCING THERAPEUTIC PROTEINS THEREFROM
#3963PROGRAMMED CELL DEATH 1 (PD1) SPECIFIC NUCLEASES
#3964METHODS AND COMPOSITIONS FOR OPTOCHEMICAL CONTROL OF CRISPR-CAS9
#3965Modified cells comprising CRISPR systems
#3966GENE TARGETS FOR T-CELL-BASED IMMUNOTHERAPY
#3967Complement Component 1s (C1s) Deficient Cells for Production of Vaccines and Biopharmaceutical Proteins
#3968NUCLEIC ACID CONSTRUCTS AND METHODS OF USE
#3969DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS
#3970Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
#3971Genetically engineered hematopoietic stem cells and uses thereof
#3972METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3973Curing for recursive nucleic acid-guided cell editing
#3974HOMOLOGY-DIRECTED REPAIR TEMPLATE DESIGN AND DELIVERY TO EDIT HEMOGLOBIN-RELATED MUTATIONS
#3975METHODS FOR EXON SKIPPING AND GENE KNOCKOUT USING BASE EDITORS
#3976Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
#3977ENGINEERED CHIMERIC NUCLEIC ACID GUIDED NUCLEASE CONSTRUCTS AND USES THEREOF
#3978Programmable Designer Therapeutic Fusogenic Secreted Gectosome Vesicles For Macromolecule Delivery And Genome Modification
#3979Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1
#3980METHODS AND COMPOSITIONS FOR NUCLEOSIDE TRIPHOSPHATE AND RIBONUCLEIC ACID PRODUCTION
#3981CHIMERIC ANTIGEN RECEPTOR T CELLS DERIVED FROM IMMUNOENGINEERED PLURIPOTENT STEM CELLS
#3982METHODS FOR COMBINATORIAL SCREENING AND USE OF THERAPEUTIC TARGETS THEREOF
#3983Method for preparing CKO/KI animal model by using CAS9 technology
#3984Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, And Liver Fibrosis
#3985Methods for improving resistance to soybean rust
#3986Methods for controlling meristem size for crop improvement
#3987Compositions and Methods for Delivering a Nucleobase Editing System
#3988Non-specific nucleases from the genus for use in facilitating flow of cells through a microfluidic channel
#3989Nuclease-mediated nucleic acid modification
#3990CRISPR-Cas effector polypeptides and methods of use thereof
#3991Mad nucleases
#3992RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY
#3993NPP1 FUSION PROTEINS
#3994SYSTEM FOR IMAGE-DRIVEN CELL MANUFACTURING
#3995METHODS OF USING DNASE1-LIKE 3 IN THERAPY
#3996CELL THERAPY
#3997Crispr effector system based coronavirus diagnostics
#3998Rapid diagnostics
#3999Methods for increasing efficiency of nuclease-induced homology-directed repair
#4000DELIVERY, ENGINEERING AND OPTIMIZATION OF TANDEM GUIDE SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#4001ENGINEERED INCOHERENT FEED FORWARD LOOP AND USES THEREOF
#4002Method for Site-Specific Mutagenesis of Medicago Sativa Genes by Using CRISPR/Cas9 System
#4003System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host
#4004Iterative genome editing in microbes
#4005Methods and compositions for directed genome editing
#4006NATURAL GUIDE ARCHITECTURES AND METHODS OF MAKING AND USING THE SAME
#4007Methods and compositions for directed genome editing
#4008Method for fragmenting DNA by nick translation
#4009ENGINEERED CHIMERIC NUCLEIC ACID GUIDED NUCLEASES COMPOSITIONS, METHODS FOR MAKING, AND SYSTEMS FOR GENE EDITING
#4010NOVEL CRISPR-ASSOCIATED PROTEIN AND USE THEREOF
#4011Type V CRISPR-Cas systems and use thereof
#4012ANTI-LIV1 IMMUNE CELL CANCER THERAPY
#4013TARGETED ELIMINATION OF BACTERIAL GENES
#4014METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST
#4015PDE3B VARIANTS
#4016THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS
#4017Compositions and methods for impeding transcription of expanded microsatellite repeats
#4018Automated cell processing methods, modules, instruments, and systems
#4019HTP genomic engineering platform for improving fungal strains
#4020RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF
#4021RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY
#4022METHODS AND COMPOSITIONS FOR GENETICALLY MANIPULATING GENES AND CELLS
#4023Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants
#4024HPV-specific binding molecules
#4025Methods and products for genetic engineering
#4026THERAPEUTIC USES OF GENOME EDITING WITH CRISPR/Cas SYSTEMS
#4027HOMOLOGY DEPENDENT REPAIR GENOME EDITING
#4028Homologous Recombination Reporter Construct and Uses Thereof
#4029Methods and compositions for sensitization of tumor cells to immune therapy
#4030CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY
#4031Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#4032Methods and compositions using one-sided transposition
#4033METHOD FOR EDITING DNA IN CELL-FREE SYSTEM
#4034MULTI-EFFECTOR NUCLEOBASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEIC ACID TARGET SEQUENCE
#4035GENETICALLY-MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE T CELL RECEPTOR ALPHA GENE
#4036ENGINEERED DNASE ENZYMES AND USE IN THERAPY
#4037ENGINEERING OF SYSTEMS, METHODS AND OPTIMIZED GUIDE COMPOSITIONS WITH NEW ARCHITECTURES FOR SEQUENCE MANIPULATION
#4038COMPOSITIONS AND METHODS OF USE OF CRISPR-CAS SYSTEMS IN NUCLEOTIDE REPEAT DISORDERS
#4039COMPOSITIONS AND METHODS FOR TREATMENT OF T CELL MALIGNANCIES
#4040Immune cell compositions and methods of use for treating viral and other infections
#4041A RODENT MODEL OF B4GALT1-MEDIATED FUNCTIONS
#4042CRISPR EFFECTOR SYSTEM BASED AMPLIFICATION METHODS, SYSTEMS, AND DIAGNOSTICS
#4043Delivery, Engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications
#4044Methods of Managing Nucleic Acid Replication, Expression, and Cleavage Using CRISPR Associated Nucleases
#4045Type VI-E and type VI-F CRISPR-Cas system and uses thereof
#4046Virus-like particles and use thereof
#4047Variants of Cpf1 (Cas12a) with altered PAM specificity
#4048CRISPR-associated (Cas) protein
#4049Simultaneous multiplex genome editing in yeast
#4050Haplotype-based treatment of RP1 associated retinal degenerations
#4051RNA-GUIDED EFFECTOR PROTEINS AND METHODS OF USE THEREOF
#4052Sideroflexins as mitochondrial serine transporters
#4053Pharmaceutical composition for topical wound treatment
#4054MULTIPLEXED IN VIVO DISEASE SENSING WITH NUCLEIC ACID-BARCODED REPORTERS
#4055RAAV-MEDIATED NUCLEASE-ASSOCIATED VECTOR INTEGRATION (RAAV-NAVI)
#4056METHOD FOR IMPROVING RICE YIELD BY JOINTLY KNOCKING OUT ABA RECEPTOR PYL FAMILY GENES AND USE THEREOF
#4057Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
#4058CORRECTION OF DYSTROPHIN EXON 43, EXON 45, OR EXON 52 DELETIONS IN DUCHENNE MUSCULAR DYSTROPHY
#4059METHOD OF USING CUT&RUN OR CUT&TAG TO VALIDATE CRISPR-CAS TARGETING
#4060VESICLES FOR TRACELESS DELIVERY OF GUIDE RNA MOLECULES AND/OR GUIDE RNA MOLECULE/RNA-GUIDED NUCLEASE COMPLEX(ES) AND A PRODUCTION METHOD THEREOF
#4061Gene editing to improve joint function
#4062Compositions and methods for treating hemoglobinopathies
#4063Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#4064Evolution of cytidine deaminases
#4065CRISPR-Cas enzymes with enhanced on-target activity
#4066Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#4067Methods and compositions for treating cancer
#4068Method of treating diseases associated with MYD88 pathways using CRISPR-GNDM system
#4069COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS
#4070Modified cells and methods of therapy
#4071Compositions and methods for organ specific delivery of nucleic acids
#4072Methods of genetic mediated engineering of RNAi models
#4073Nuclease profiling system
#4074CRISPR enabled multiplexed genome engineering
#4075Methods for scarless introduction of targeted modifications into targeting vectors
#4076Composition for editing flavonoid biosynthetic gene by using CRISPR/Cas9 system, and use thereof
#4077GENOME ENGINEERING PRIMARY MONOCYTES
#4078Compositions and methods for gene editing by targeting transferrin
#4079Artificially-manipulated neovascularization regulatory system
#4080Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#4081Synthetic RNA binding polypeptides
#4082CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#4083Use of Polypeptide
#4084COMPOSITIONS AND METHODS FOR INHIBITING ENDOGENOUS IMMUNOGLOBULIN GENES AND PRODUCING TRANSGENIC HUMAN IDIOTYPE ANTIBODIES
#4085Compositions and methods for treating hemoglobinopathies
#4086METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#4087Gene editing to improve joint function
#4088Materials and methods for engineering cells and uses thereof in immuno-oncology
#4089Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
#4090MODIFIED CAS9 PROTEIN, AND USE THEREOF
#4091DOWN-REGULATION OF THE CYTOSOLIC DNA SENSOR PATHWAY
#4092MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI
#4093COMPLEX FOR THE DELIVERY OF CAS9 PROTEINS AND GUIDE RNA TO CELLS
#4094REGULATABLE GENE EDITING COMPOSITIONS AND METHODS
#4095Electrochemical biosensor
#4096Methods and compositions for treating cancer
#4097ENGINEERED CELLS WITH MODIFIED HOST CELL PROTEIN PROFILES
#4098COMPOSITIONS AND METHODS FOR REDUCING CAFFEINE CONTENT IN COFFEE BEANS
#4099METHODS AND COMPOSITIONS FOR HOMOLOGY DIRECTED REPAIR OF DOUBLE STRAND BREAKS IN PLANT CELL GENOMES
#4100TYPE V CRISPR/NUCLEASE-SYSTEM FOR GENOME EDITING IN PLANT CELLS
#4101COMPOSITIONS, SYSTEMS, AND METHODS FOR BASE DIVERSIFICATION
#4102Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cells
#4103CRISPR-Cas effector polypeptides and methods of use thereof
#4104High fidelity restriction endonucleases
#4105AUTOMATED PRODUCTION OF CAR-EXPRESSING CELLS
#4106De Novo Formation of the Biliary System by Hepatocyte Transdifferentiation
#4107PRODUCING RECOMBINANT PROTEINS WITH REDUCED LEVELS OF HOST CELL PROTEINS
#4108Genetically engineered hematopoietic stem cells and uses thereof
#4109Materials and methods for engineering cells and uses thereof in immuno-oncology
#4110Compositions and methods for the treatment of expanded repeat-associated disorders
#4111BIOSENSOR
#4112LABELING OF DNA
#4113Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4114SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
#4115NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY CARRIER SET, NUCLEIC ACID DELIVERY COMPOSITION, AND NUCLEIC ACID DELIVERY METHOD
#4116GENE THERAPY FOR CNS DEGENERATION
#4117Gene Targeting
#4118Methods and systems of molecular recording by CRISPR-Cas system
#4119High fidelity restriction endonucleases
#4120Cytosine to guanine base editor
#4121MICROHOMOLOGY MEDIATED REPAIR OF MICRODUPLICATION GENE MUTATIONS
#4122Mutant CPF1 endonucleases
#4123Use of Polypeptide
#4124PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#4125Genetically engineered hematopoietic stem cells and uses thereof
#4126Targeted replacement of endogenous T cell receptors
#4127GENERATION OF KNOCK-OUT PRIMARY AND EXPANDED HUMAN NK CELLS USING CAS9 RIBONUCLEOPROTEINS
#4128Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4129CATALYTICALLY INACTIVE TRUNCATED GUIDE RNA COMPOSITIONS AND RELATED METHODS FOR SUPPRESSION OF CRISPR/CAS OFF-TARGET EDITING
#4130RNA-Guided Human Genome Engineering
#4131Compositions and Methods for Lactate Dehydrogenase (LDHA) Gene Editing
#4132CRISPR/CAS9 SYSTEMS, AND METHODS OF USE THEREOF
#4133CRISPR-CAS SYSTEMS HAVING DESTABILIZATION DOMAIN
#4134AUTOMATED CELL PROCESSING METHODS, MODULES, INSTRUMENTS, AND SYSTEMS
#4135TARGETED TREATMENT OF LEBER CONGENITAL AMOUROSIS
#4136GENE-DRIVE IN DNA VIRUSES
#4137Compositions and methods for genome engineering with Cas12a proteins
#4138Single adeno-associated virus (AAV)-sized nucleotide for use in CRISPR interference or activation
#4139INDUCTION OF DNA STRAND BREAKS AT CHROMATIN TARGETS
#4140Genetically engineered hematopoietic stem cells and uses thereof
#4141NON-DISRUPTIVE GENE TARGETING
#4142Nucleic acid modifiers
#4143MATERIALS AND METHODS FOR TREATING CANCER
#4144CBLB endonuclease variants, compositions, and methods of use
#4145CBLB endonuclease variants, compositions, and methods of use
#4146METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION
#4147CAS9 VARIANTS AND USES THEREOF
#4148Class 2 CRISPR/Cas compositions and methods of use
#4149Drug-Resistant Immune Cells and Methods of Use Thereof
#4150CRISPR DOUBLE NICKASE BASED AMPLIFICATION COMPOSITIONS, SYSTEMS, AND METHODS
#4151COMPOUND FOR REGULATING GENE EDITING EFFICIENCY AND APPLICATION THEREOF
#4152CRISPR-BASED GENOME MODIFICATION AND REGULATION
#4153VIRAL DELIVERY OF RNA UTILIZING SELF-CLEAVING RIBOZYMES AND CRISPR-BASED APPLICATIONS THEREOF
#4154CRISPR-BASED GENOME MODIFICATION AND REGULATION
#4155Programmable and portable CRISPR-Cas transcriptional activation in bacteria
#4156RECONSTITUTION OF DNA-END REPAIR PATHWAY IN PROKARYOTES
#4157Reverse transcriptases and uses thereof
#4158METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS
#4159Compositions and methods for promoting homology directed repair mediated gene editing
#4160Engineering of DNASE enzymes for manufacturing and therapy
#4161Immunogenic composition comprising a recombinant attenuated mopeia virus with a modified nucleoprotein displaying reduced exonuclease activity
#4162Method for detecting on-target and predicted off-target genome editing events
#4163KIT FOR REPARING FBN1T7498C MUTATION, COMBINATION FOR MAKING AND REPAIRING MUTATION, AND METHOD OF REPAIRING THEREOF
#4164Gene editing method using virus
#4165Method for knocking out N-myristoyltransferase (NMT) gene from
#4166NOVEL CRISPR-ASSOCIATED SYSTEMS AND COMPONENTS
#4167COMPOSITIONS AND METHODS FOR MAKING GUIDE NUCLEIC ACIDS
#4168COMPOSITIONS AND METHODS FOR IMPROVED NUCLEASES
#4169MAD nucleases
#4170Base editors and uses thereof
#4171MODULATED CAS-INHIBITORS
#4172SEQUENCE DETECTION SYSTEMS
#4173Compositions and methods for targeted depletion, enrichment, and partitioning of nucleic acids using CRISPR/Cas system proteins
#4174System for DNA editing and uses thereof
#4175CRISPR INTERFERENCE BASED HTT ALLELIC SUPPRESSION AND TREATMENT OF HUNTINGTON DISEASE
#4176Creation of herbicide resistant gene and use thereof
#4177Single-vector type I vectors
#4178Methods and compositions for regulation of transgene expression
#4179METHOD FOR PRODUCING FUSION PROTEIN, NUCLEIC ACID, CELL, AND ANIMAL
#4180DNA-guided gene editing and regulation
#4181GENE EDITING SYSTEM OF PSEUDOMONAS PUTIDA AND GENE EDITING METHOD THEREOF
#4182NUCLEIC ACID CONSTRUCT, MEDICINAL COMPOSITION, ANTICANCER AGENT, ANTIVIRAL AGENT AND ANTIBACTERIAL AGENT
#4183Method for regulating gene expression
#4184Detergent composition comprising a DNase
#4185DOWNREGULATION OF SNCA EXPRESSION BY TARGETED EDITING OF DNA-METHYLATION
#4186METHODS AND COMPOSITIONS FOR GENOME ENGINEERING
#4187IPSC-DERIVED SECRETOME COMPOSITIONS, AND RELATED SYSTEMS AND METHODS
#4188TALEN-BASED GENE CORRECTION
#4189Nucleic acid-guided nucleases
#4190IN SITU GENE EDITING
#4191Compositions and methods for genome editing in plants
#4192Abiotic stress tolerant plants and polynucleotides to improve abiotic stress and methods
#4193GENOME EDITING IN BACTEROIDES
#4194COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY OF CAS9-BASED KNOCK-IN STRATEGIES
#4195Systems and methods for gene modification
#4196SYNTHETIC RNAS AND METHODS OF USE
#4197Automated cell processing methods, modules, instruments, and systems
#4198SCALABLE TAGGING OF ENDOGENOUS GENES BY HOMOLOGY-INDEPENDENT INTRON TARGETING
#4199Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome
#4200Enhanced immune effector cells and use thereof